Ondine Biomedical (FRA:VF5) Interest Expense: €-0.03 Mil (TTM As of Dec. 2024)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.15
View Full Analysis

What is Ondine Biomedical Interest Expense?

Ondine Biomedical FRA:VF5 47 Interest Expense is €-0.03 Mil as of Dec. 2024. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ondine Biomedical's interest expense for the six months ended in Dec. 2024 was € -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ondine Biomedical's Operating Income for the six months ended in Dec. 2024 was € -7.79 Mil. Ondine Biomedical's Interest Expense for the six months ended in Dec. 2024 was € -0.02 Mil. Ondine Biomedical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ondine Biomedical  (FRA:VF5) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ondine Biomedical's Interest Expense for the six months ended in Dec. 2024 was €-0.02 Mil. Its Operating Income for the six months ended in Dec. 2024 was €-7.79 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was €0.00 Mil.

Ondine Biomedical's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Ondine Biomedical did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Ondine Biomedical Interest Expense Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Interest Expense Chart

Ondine Biomedical Annual Data
Trend Dec09 Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.32 -0.84 -0.02 -0.03 -0.03

Ondine Biomedical Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.01 -0.02 -0.02
FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of €-0.03 Mil mean?
Ondine Biomedical (FRA:VF5) has a Interest Expense of €-0.03 Mil as of Dec. 2024. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Interest Expense too high?
Ondine Biomedical's current Interest Expense is €-0.03 Mil. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Interest Expense compare to VRTX and REGN?
Ondine Biomedical's Interest Expense of €-0.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current Interest Expense is €-0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current Interest Expense of €-0.03 Mil. The current Interest Expense is €-0.03 Mil. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current Interest Expense is €-0.03 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price